{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:36:54Z","timestamp":1782963414168,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MD Anderson Gynecologic SPORE for Uterine Cancer","award":["2P50CA098258"],"award-info":[{"award-number":["2P50CA098258"]}]},{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ygyno.2018.11.027","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:30:28Z","timestamp":1552429828000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Women's preferences for cancer risk management strategies in Lynch syndrome"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-7853","authenticated-orcid":false,"given":"Charlotte C.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly S.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-3368","authenticated-orcid":false,"given":"Denise R.","family":"Nebgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Burton-Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2018.11.027_bb0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ijc.2910640613","article-title":"Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome","volume":"64","author":"Aarnio","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.027_bb0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cgh.2007.02.019","article-title":"Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer","volume":"5","author":"Diergaarde","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.027_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective lynch syndrome database","volume":"66","author":"Moller","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.ygyno.2018.11.027_bb0020","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75\u202fyears of age: a report from the prospective lynch syndrome database","volume":"67","author":"Moller","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ygyno.2018.11.027_bb0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3892\/mco.2017.1211","article-title":"Comparison of lifestyle, hormonal and medical factors in women with sporadic and lynch syndrome-associated endometrial cancer: a retrospective case-case study","volume":"6","author":"Aaltonen","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ygyno.2018.11.027_bb0035","series-title":"Genetic\/Familial High-Risk Assessment: Colorectal (Version 1.2018 - July 12, 2018)","article-title":"National Comprehensive Cancer Network","year":"2018"},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.027_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2018.11.027_bb0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.seminoncol.2016.08.005","article-title":"Genetic predisposition in gynecologic cancers","volume":"43","author":"Daniels","year":"2016","journal-title":"Semin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2018.11.027_bb0050","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1517\/14740338.2014.951327","article-title":"Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer","volume":"13","author":"Davidson","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.027_bb0055","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/cncr.10380","article-title":"The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma","volume":"94","author":"Dove-Edwin","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","article-title":"Gynecologic screening in hereditary nonpolyposis colorectal cancer","volume":"91","author":"Rijcken","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.027_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2011.04.004","article-title":"Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1\/2 mutation carriers","volume":"122","author":"Chapman","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10689-017-9997-6","article-title":"Quality of life following prophylactic gynecological surgery: experiences of female lynch mutation carriers","volume":"17","author":"Etchegary","year":"2018","journal-title":"Familial Cancer"},{"issue":"3 Suppl","key":"10.1016\/j.ygyno.2018.11.027_bb0075","doi-asserted-by":"crossref","first-page":"e24s","DOI":"10.1200\/JOP.2011.000535","article-title":"Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome","volume":"8","author":"Wang","year":"2012","journal-title":"J. Oncol. Pract."},{"issue":"5","key":"10.1016\/j.ygyno.2018.11.027_bb0080","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/annonc\/mdr559","article-title":"Preferences for cancer treatments: an overview of methods and applications in oncology","volume":"23","author":"Blinman","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.027_bb0085","series-title":"Second Edition: Oxford Medical Publications","article-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1997"},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.2001.19.1.220","article-title":"Patient preference for cancer therapy: an overview of measurement approaches","volume":"19","author":"Stiggelbout","year":"2001","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2018.11.027_bb0095","series-title":"McMaster University Centre for Health Economics and Policy Analysis Working Paper No 90-9, 1990","article-title":"Guide to design and development of health-state utility instrumentation","author":"Furlong William","year":"1990"},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.027_bb0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/IGC.0000000000000149","article-title":"Patient preferences for side effects associated with cervical cancer treatment","volume":"24","author":"Sun","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2018.11.027_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/cge.12246","article-title":"Gynecologic cancer screening and communication with health care providers in women with lynch syndrome","volume":"86","author":"Burton-Chase","year":"2014","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.027_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/pmed.1999.0524","article-title":"Bilateral prophylactic mastectomy decision making: a vignette study","volume":"29","author":"Stefanek","year":"1999","journal-title":"Prev. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.027_bb0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/humu.22262","article-title":"Cancer risks for MLH1 and MSH2 mutation carriers","volume":"34","author":"Dowty","year":"2013","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/GCO.0b013e32801195da","article-title":"Prophylactic oophorectomy in women at increased cancer risk","volume":"19","author":"Domchek","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"3\u20134","key":"10.1016\/j.ygyno.2018.11.027_bb0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1021119405814","article-title":"Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer","volume":"1","author":"Elit","year":"2001","journal-title":"Familial Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13053-015-0031-4","article-title":"Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female lynch syndrome mutation carriers","volume":"13","author":"Etchegary","year":"2015","journal-title":"Hered. Cancer. Clin. Pract."},{"issue":"4b","key":"10.1016\/j.ygyno.2018.11.027_bb0145","first-page":"1675","article-title":"The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer","volume":"14","author":"Vasen","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2018.11.027_bb0150","doi-asserted-by":"crossref","first-page":"583891","DOI":"10.1155\/2013\/583891","article-title":"Contemporary clinical management of endometrial cancer","volume":"2013","author":"Dinkelspiel","year":"2013","journal-title":"Obstet. Gynecol. Int."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JOP.2010.000038","article-title":"Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach","volume":"7","author":"Huang","year":"2011","journal-title":"J. Oncol. Pract."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2014.08.017","article-title":"Combined colonoscopy and endometrial biopsy cancer screening results in women with lynch syndrome","volume":"135","author":"Nebgen","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2018.11.027_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","article-title":"Cancer risk associated with germline DNA mismatch repair gene mutations","volume":"6","author":"Dunlop","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.ygyno.2018.11.027_bb0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jamaoncol.2018.0104","article-title":"Assessment of tumor sequencing as a replacement for lynch syndrome screening and current molecular tests for patients with colorectal cancer","volume":"4","author":"Hampel","year":"2018","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.11.027_bb0175","first-page":"260","article-title":"Challenges to the translation of genomic information into clinical practice and health policy: utilization, preferences, and economic value","volume":"10","author":"Phillips","year":"2008","journal-title":"Curr. Opin. Mol. Ther."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818314471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:41:10Z","timestamp":1758771670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818314471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0090825818314471"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.027","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women's preferences for cancer risk management strategies in Lynch syndrome","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}